Skip to content
10-Q

Quarterly Report

Infinity Pharmaceuticals, Inc.

0001113148-23-000006

← back to feed
Filed
May 9, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 2, 2023 89.9M sh
Shares Diluted Q1 2023 · Mar 31, 2023 89.41M sh
Shares Diluted Q1 2023 · Mar 31, 2022 89.16M sh
Capex Q1 2023 · Mar 31, 2023 $0
Capex Q1 2023 · Mar 31, 2022 $17K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$12.58M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$13.54M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $25.74M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $38.31M
Cash And Equivalents Q1 2023 · Mar 31, 2022 $53.13M
Stockholders Equity Q1 2023 · Mar 31, 2023 −$28.32M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$19.05M
Stockholders Equity Q1 2023 · Mar 31, 2022 $9.98M
Stockholders Equity Q1 2023 · Dec 31, 2021 $21.57M
Current Liabilities Q1 2023 · Mar 31, 2023 $11.29M
Current Liabilities Q1 2023 · Dec 31, 2022 $13.63M
Total Liabilities Q1 2023 · Mar 31, 2023 $58.27M
Total Liabilities Q1 2023 · Dec 31, 2022 $61.2M
Current Assets Q1 2023 · Mar 31, 2023 $28.36M
Current Assets Q1 2023 · Dec 31, 2022 $40.3M
Total Assets Q1 2023 · Mar 31, 2023 $29.95M
Total Assets Q1 2023 · Dec 31, 2022 $42.15M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.12
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.14
Eps Basic Q1 2023 · Mar 31, 2023 −$0.12
Eps Basic Q1 2023 · Mar 31, 2022 −$0.14
Sga Expense Q1 2023 · Mar 31, 2023 $5.94M
Sga Expense Q1 2023 · Mar 31, 2022 $3.68M
Rd Expense Q1 2023 · Mar 31, 2023 $5.85M
Rd Expense Q1 2023 · Mar 31, 2022 $8.99M
Net Income Q1 2023 · Mar 31, 2023 −$11.05M
Net Income Q1 2023 · Mar 31, 2022 −$12.44M
Operating Income Q1 2023 · Mar 31, 2023 −$11.51M
Operating Income Q1 2023 · Mar 31, 2022 −$12.41M
Revenue Q1 2023 · Mar 31, 2023 $731K
Revenue Q1 2023 · Mar 31, 2022 $652K